Contact Information:
J. Spencer Hauck investigated new therapeutic interventions for human disease for 10 years, which led to 13 peer-reviewed publications. He joined Duke University as a postdoctoral researcher in 2019 to discover new ways to treat therapy-resistant prostate cancer. Spencer identified a method to selectively kill the most aggressive form of prostate cancer and was awarded 2 fellowships during his post-doctoral studies, including a TL1 fellowship through Duke Clinical and Science Translational Institute (CTSI) and a Department of Defense Early Investigator Award. Spencer joined CTSI in 2024, and he has roles in the Office of Physician-Scientist Development and the Center for Pathway Programs.
Spencer holds a PhD in Molecular Biology from The Ohio State University.